Pain Management News

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

The FDA has granted fast track designation to a sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride for the management of fibromyalgia, according to a press release from the manufacturer.

A self-management program tailored to individuals with HIV significantly reduced the impact and severity of chronic pain, according to results from a randomized study published in JAMA Internal Medicine.

Acupuncture was superior to sham acupuncture in reducing methadone doses and opioid cravings in patients undergoing treatment for opioid addiction, findings showed.

A recently published case report summarized the successful initiation of buprenorphine treatment in two adolescents who presented to a pediatric ED with opioid withdrawal.

More than six in 10 Americans were unaware that primary care providers can prescribe treatment for opioid use disorder, or OUD, according to survey results published in JAMA Network Open.

Few individuals received medications for opioid use disorder or filled a naloxone prescription after a nonfatal drug overdose, despite the benefits of these treatments in reducing the odds for a future fatal overdose, data show.

Nearly one-quarter of outpatient visits by patients with systemic autoimmune rheumatic diseases in the United States between 2006 and 2019 resulted in an opioid prescription, according to data published in Arthritis Care & Research.

The U.S. Supreme Court ruled 5-4 on Thursday that members of the Sackler family cannot be protected from future lawsuits for their roles in the opioid epidemic.

Healio has launched a new special report on medical cannabis that summarizes the current scientific research and incorporates expert opinion.